Get the latest news and live updates as the government shutdown enters Day 37, with FAA cuts to flights and energy bill assistance cuts looming.

U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...

Donald Trump has unveiled a deal to slash the price of GLP-1 weight loss drugs by two thirds. The White House’s deal with Novo Nordisk and Eli Lilly will see the prices of WeGovy and Ozempic, also ...

Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech ...

Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March ...

Michael Landsberg, chief investment officer at Landsberg Bennett Private Wealth Management, explained why shares of Novo ...

In a move reverberating across global healthcare and financial markets, Donald Trump has announced a deal to cap insulin ...

The Supreme Court ruled Thursday that the Trump administration can order US passports indicate the holders’ sex at birth and ...

U.S. Health Secretary Robert F. Kennedy Jr. says the new guidelines will change the food culture in this country.

The Pfizer and Novo Nordisk battle for obesity drug developer Metsera intensified on Thursday after a fresh round of ...

President Trump, Lilly, and Novo Nordisk agree to lower prices of GLP-1 weight-loss drugs for Medicare, Medicaid, and cash ...

PFIZER plans to sweeten its bid for Metsera, a person familiar with the matter told Reuters, after a judge denied its request to block rival drugmaker Novo Nordisk’s $10-billion offer for the biotech ...